-
公开(公告)号:US08299026B2
公开(公告)日:2012-10-30
申请号:US12375008
申请日:2007-07-25
CPC分类号: A61K47/61 , A61K38/00 , A61K38/1816 , A61K38/193 , A61K38/465 , C07K14/505 , C07K14/52 , C07K14/535 , C07K14/575 , C12N9/22 , C12Y301/21001 , Y02A50/473
摘要: The present invention relates to a compound which is a polysaccharide derivative of EPO, or of an EPO like protein, wherein the polysaccharide is anionic and comprises between 2 and 200 saccharide units. The present invention also relates to pharmaceutical compositions comprising the novel compounds, and methods for making the novel compounds.
摘要翻译: 本发明涉及作为EPO的多糖衍生物或EPO样蛋白质的化合物,其中所述多糖是阴离子型的,并且包含2至200个糖单元。 本发明还涉及包含新化合物的药物组合物和制备新化合物的方法。
-
公开(公告)号:US20100022443A1
公开(公告)日:2010-01-28
申请号:US12375008
申请日:2007-07-25
CPC分类号: A61K47/61 , A61K38/00 , A61K38/1816 , A61K38/193 , A61K38/465 , C07K14/505 , C07K14/52 , C07K14/535 , C07K14/575 , C12N9/22 , C12Y301/21001 , Y02A50/473
摘要: The present invention relates to a compound which is a polysaccharide derivative of EPO, or of an EPO like protein, wherein the polysaccharide is anionic and comprises between 2 and 200 saccharide units. The present invention also relates to pharmaceutical compositions comprising the novel compounds, and methods for making the novel compounds.
摘要翻译: 本发明涉及作为EPO的多糖衍生物或EPO样蛋白质的化合物,其中所述多糖是阴离子型的,并且包含2至200个糖单元。 本发明还涉及包含新化合物的药物组合物和制备新化合物的方法。
-